Background Psoriatic arthritis (PsA) is a clinically heterogeneous disease. Clear consensual
treatment guidance focused on the musculoskeletal manifestations of PsA would be …

Objectives To review the available evidence for the efficacy and safety of non-steroidal anti-
inflammatory drugs (NSAIDs), synthetic and biological drug therapies for the different clinical …

Structural changes of bone and cartilage are a hallmark of inflammatory joint diseases such
as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) …

Objective Enthesopathy is a major feature of psoriatic arthritis (PsA), which is supported by
imaging studies. Given that nail disease often predates PsA and that the nail is directly …

Objective: We compared ultrasonography (US) with the modified nail psoriasis severity
index (mNAPSI) to investigate the nail plate, nail matrix and adjacent tendons in subjects …

Evaluation of the preclinical phases of the classic autoimmune diseases including
rheumatoid arthritis has been facilitated by the availability of autoantibody and genetic …

Objective Subclinical enthesopathy is recognised in both psoriasis and psoriatic arthritis
(PsA). This study used ultrasonography with power Doppler (PD) to test the hypothesis that …

Objective. Synovitis is very common in knee OA and associated with pain. This open-label
study evaluated an anti-synovitis therapy, MTX, for pain relief in knee OA. Methods. Inclusion …

Background: Psoriatic nail disease is increasingly recognised to be of major clinical and
research relevance. Clinical assessment remains the current gold standard for its …

Introduction: The introduction of biological treatments has improved the outlook for patients
diagnosed with rheumatoid arthritis. There are now a range of different agents, targeting …